Filoviruses, Ebola viruses (EBOV) and Marburg viruses (MBGV) (NIAID category A), are extremely virulent causes of viral hemorrhagic fever. Effective small molecule anti-filovirus therapies are still lacking for these important biodefense pathogens. It has been previously demonstrated that EBOV or MBGV infection impairs the capacity of cells to produce interferon (IFN)-alpha/beta and impairs cellular responses to interferon (IFN)- alpha/beta and to IFN-gamma. These capacities likely contribute to the rapid in vivo dissemination of filoviruses and promote systemic filovirus infection and facilitate the replication of filoviruses in vivo. Defining the viral factors that block cellular responses to IFN should shed light on filoviral pathogenesis. The identification of compounds that block the function of filovirus-encoded IFN-antagonists could augment the efficacy of IFN produced during the course of viral infection or the efficacy of IFN administered as an antiviral treatment. We have identified the VP24 protein of EBOV and the VP40 protein of MBGV as inhibitors of IFN signaling. This proposal will capitalize upon the identification of the EBOV VP24 and MBGV VP40 as inhibitors of IFN signaling. We have already demonstrated that the EBOV VP24 inhibits the nuclear accumulation of activated STAT1, and preliminary data demonstrates that MBGV VP40 inhibits STAT1 and STAT2 tyrosine phosphorylation. Based upon these observations, the specific aims of this proposal are to (1) Define the mechanism by which the MBGV VP40 protein inhibits host cell IFN signaling;(2) Assess the importance of VP24 and VP40 for inhibition of IFN signaling in EBOV- or MBGV-infected cells;(3) Develop screens to identify inhibitors of EBOV VP24 and MBGV VP40 IFN-antagonist function;and (4) Identify small molecules that inhibit EBOV VP24 and MBGV VP40 function.
Ebola virus and Marburg virus are important, highly lethal biodefense pathogens, and insights into their pathogenesis are badly needed. Also needed are effective therapeutics targeting these viruses. This proposal seed to define critical aspects of virus pathogenesis, how these viruses evade innate immunity, and to develop drugs that inhibit these viral functions.
|Charles, Jermilia; Firth, Andrew E; LoroÃ±o-Pino, Maria A et al. (2016) Merida virus, a putative novel rhabdovirus discovered in Culex and Ochlerotatus spp. mosquitoes in the Yucatan Peninsula of Mexico. J Gen Virol 97:977-87|
|Pham, Alissa M; Santa Maria, Felicia Gilfoy; Lahiri, Tanaya et al. (2016) PKR Transduces MDA5-Dependent Signals for Type I IFN Induction. PLoS Pathog 12:e1005489|
|Song, Jeongmin; Wilhelm, Cara L; Wangdi, Tamding et al. (2016) Absence of TLR11 in Mice Does Not Confer Susceptibility to Salmonella Typhi. Cell 164:827-8|
|Li, Melody M H; Bozzacco, Leonia; Hoffmann, Hans-Heinrich et al. (2016) Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion. J Exp Med 213:2931-2947|
|Moser, Lindsey A; Lim, Pei-Yin; Styer, Linda M et al. (2016) Parameters of Mosquito-Enhanced West Nile Virus Infection. J Virol 90:292-9|
|Basu, Debaleena; Kahn, Jennifer N; Li, Xiao-Ping et al. (2016) Conserved Arginines at the P-Protein Stalk Binding Site and the Active Site Are Critical for Ribosome Interactions of Shiga Toxins but Do Not Contribute to Differences in the Affinity of the A1 Subunits for the Ribosome. Infect Immun 84:3290-3301|
|Steyer, Andrej; JevÅ¡nik, Monika; Petrovec, Miroslav et al. (2016) Narrowing of the Diagnostic Gap of Acute Gastroenteritis in Children 0-6 Years of Age Using a Combination of Classical and Molecular Techniques, Delivers Challenges in Syndromic Approach Diagnostics. Pediatr Infect Dis J 35:e262-70|
|Uhde, Melanie; Ajamian, Mary; Li, Xueting et al. (2016) Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease. Clin Infect Dis 63:1399-1404|
|Jacek, Elzbieta; Tang, Kevin S; Komorowski, Lars et al. (2016) Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease. J Immunol 196:1036-43|
|Aguilar, Jorge L; Varshney, Avanish K; Pechuan, Ximo et al. (2016) Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus. Virulence :1-10|
Showing the most recent 10 out of 643 publications